Trimi

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• Compounded semaglutideCompounded · not FDA-approved
• Compounded tirzepatideCompounded · not FDA-approved

What they publish

Trimi publishes 3 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

From $99/month, with a $125/month tier also published (as published)

Medication cost

Not publicly disclosed on the pages we captured.

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

States prescribing is by US-licensed clinicians.

Eligibility

Not publicly disclosed on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

States medication is shipped to the patient.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• Among the lowest published all-in compounded pricing in the directory.
• Stating that prescribers are US-licensed is a basic assurance, though every legitimate service should meet it.
• Two tiers published without a clear on-page explanation of the difference.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• Establish what separates the $99 and $125 tiers.
• Confirm the price holds as your dose escalates.
• Ask which pharmacy compounds it and whether it is 503A or 503B.